Sitemap > Breaking Research > Infectious Diseases
Displaying 901 - 950 of 4290 results
- Biological treatment in rheumatic diseases: results from a longitudinal surveillance: adverse events.
- Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis.
- Inhibition of hepatitis B virus replication by recombinant small interfering RNAs.
- Inhaled nitric oxide alleviates hyperoxia suppressed phosphatidylcholine synthesis in endotoxin-induced injury in mature rat lungs.
- Synthesis and screening of bicyclic carbohydrate-based compounds: a novel type of antivirals.
- Syntheses of glucose analogues of E5564 as a highly potent anti-sepsis drug candidate.
- Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.
- Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening.
- Elevation of the efficacy of antitumor vaccine prepared on the base of lectines from B. subtilis B-7025 upon its combined application with probiotics in vivo.
- Nanodecoy system: a novel approach to design hepatitis B vaccine for immunopotentiation.
- A randomized trial of inhaled cyclosporine in lung-transplant recipients.
- Butyrate modulates TGF-beta1 generation and function: potential renal benefit for Acacia(sen) SUPERGUM (gum arabic)?
- The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice.
- Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).
- Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial.
- Identification and characterization of O-acetylpeptidoglycan esterase: a novel enzyme discovered in Neisseria gonorrhoeae.
- Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis.
- BACE-1 inhibitory activities of new substituted phenyl-piperazine coupled to various heterocycles: chromene, coumarin and quinoline.
- Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.
- Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis.
- The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors.
- Novel inhibitors of hepatitis C NS3-NS4A serine protease derived from 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid.
- Schiff base conjugates of p-aminosalicylic acid as antimycobacterial agents.
- Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
- Identification of a potent and selective non-basic cathepsin K inhibitor.
- 1-Phenyl-8-azabicyclo[3.2.1]octane ethers: a novel series of neurokinin (NK1) antagonists.
- Near-infrared spectroscopy: promising diagnostic tool for viral infections.
- Effects of macrophage inducible nitric oxide synthase in murine septic lung injury.
- Transforming growth factor-beta1 increases airway wound repair via MMP-2 upregulation: a new pathway for epithelial wound repair?
- Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms.
- Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice.
- A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.
- NF-kappaB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in dextran sulfate sodium-induced colitis in rats.
- Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients.
- Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure.
- Levosimendan protects against experimental endotoxemic acute renal failure.
- The impact of empiric antimicrobial therapy with a beta-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
- Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury.
- Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
- Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders.
- A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling.
- The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.
- Formoterol, 24 microg bid, and serious asthma exacerbations: similar rates compared with formoterol, 12 microg bid, with and without extra doses taken on demand, and placebo.
- Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.
- Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
- Sepsis in European intensive care units: results of the SOAP study.
- Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis.
- Toll-like receptor 4 plays an anti-HBV role in a murine model of acute hepatitis B virus expression.
- AEOL-10150 (Aeolus).
- BTLA, a new inhibitory B7 family receptor with a TNFR family ligand.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 Next >